Regulatory & Legal

Dr. Jesse Ehrenfeld's jump to Aidoc validates enterprise AI's role in medicine, as the tech giant surpasses 100 million patient scans analyzed.

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

New system from Montrose tackles a major methane source, promising greater accuracy, technician safety, and faster action on climate goals.

A new mobile app from Reliance Matrix and AllOne Health uses an AI navigator to provide instant, personalized EAP support, aiming to boost low usage.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

Health tech firm IMVARIA, maker of an FDA-authorized AI for lung disease, has secured strategic funding from InHealth Ventures and Labcorp to expand its reach.

A new partnership brings a complex wealth-building insurance product to the digital age, offering instant decisions and no medical exams. Is this the future?

Universal Insurance Holdings announces a new $20M stock buyback, signaling strong financial health and confidence amidst a stabilizing Florida market.

Backed by the LEGO family's firm, Adapture Renewables secures major U.S. Bank financing to build out its 441 MW Titanium solar portfolio in IL and AR.

Kelonia Therapeutics gets the FDA green light to expand trials for its in vivo CAR-T therapy, a single-infusion treatment that could redefine cancer care.

LUMA Vision's VERAFEYE™ system combines AI with real-time 4D heart visualization, promising to make complex AFib procedures faster, safer, and more precise.

As millions of solar panels near retirement, a Nevada facility gets the final go-ahead to turn a looming waste crisis into a source of valuable materials.

Beauty giant L'Oréal partners with LED innovator iSMART, signaling a new era of professional-grade light therapy devices for your daily routine.

At CES 2026, a new $39,900 personal eVTOL promises flight for all, no license needed. But can it safely navigate regulatory and public trust hurdles?

Rumble moves forward with its transformative Northern Data acquisition, aiming for AI dominance, but a major tax fraud probe in Europe looms over the deal.

Shareholders greenlight a deal creating the 9th largest U.S. bank. This mega-merger promises growth but faces a complex road of integration and change.

Harvard Pilgrim's annual Honor Roll names 34 top physician groups, using rigorous national data to guide patients to the highest quality of care.

A new nationwide study reveals a massive gap in care for heart failure patients, costing lives and billions. Why are proven, cheap medications being overlooked?